Strides Pharma Science Shows Strong Performance Amid Positive Midcap Pharmaceutical Trends

Strides Pharma Science has shown notable activity today, gaining 5.18% as of March 18, 2025. The stock has outperformed its sector by 3.87%, reflecting a positive trend in the midcap pharmaceuticals and drugs industry. Over the past two days, Strides Pharma has recorded a cumulative return of 5.71%, indicating a consistent upward movement.
The stock reached an intraday high of Rs 625.1, marking a 5.41% increase during the trading session. In terms of moving averages, Strides Pharma's performance is currently above its 5-day and 200-day moving averages, although it remains below the 20-day, 50-day, and 100-day moving averages.

In the broader market context, the Sensex has also experienced a rise, climbing 316.67 points to reach 74,925.33, with small-cap stocks leading the market gains. Despite a mixed performance over various time frames, Strides Pharma Science has demonstrated significant growth over the past year, with a remarkable 62.44% increase compared to the Sensex's 2.89%. This performance highlights the company's resilience and position within the competitive landscape of the pharmaceuticals sector.